Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan, 430060, People's Republic of China.
Clin Res Cardiol. 2011 Jan;100(1):37-43. doi: 10.1007/s00392-010-0201-3. Epub 2010 Jul 21.
The feasibility and safety of the transradial approach for catheter ablation of idiopathic left ventricular tachycardia (ILVT) have not been evaluated. The aim of this study was to investigate the feasibility and safety of transradial approach for catheter ablation in ILVT patients.
Thirty consecutive ILVT patients with negative Allen's test undergoing catheter ablation via transradial approach were enrolled to compare the safety and efficacy with 30 other ILVT patients who previously underwent catheter ablation via transfemoral approach.
Ablation was successfully performed in all patients. In the transradial group, the total procedural and the fluoroscopy time (42.8 ± 6.9 min and 9.7 ± 1.9 min, respectively) were significantly shorter when compared with transfemoral group (52.8 ± 8.4 min and 11.5 ± 2.1 min, respectively) (both P < 0.05). The two groups were similar in the number of current applications (4.1 ± 0.8 vs. 4.4 ± 1.1, P > 0.05), the power energy (47.3 ± 7.3 vs. 49.7 ± 6.9 W, P > 0.05), and the total duration of current application (110.3 ± 15.6 vs. 112.3 ± 16.5 s, P > 0.05), respectively. The duration of hospitalization in transradial group was shorter than that in transfemoral group (4.1 ± 0.9 vs. 5.8 ± 1.1 days, P < 0.05). During follow-up, there was no recurrence of tachycardia in all patients. One patient in transfemoral group developed access site complications while none occurred in the transradial group.
The transradial approach is feasible and safe for catheter ablation of ILVT.
经桡动脉入路行特发性左室室性心动过速(ILVT)导管消融的可行性和安全性尚未得到评估。本研究旨在探讨经桡动脉入路行 ILVT 导管消融的可行性和安全性。
连续纳入 30 例经桡动脉入路行 ILVT 导管消融且 Allen 试验阴性的患者,并与 30 例先前经股动脉入路行 ILVT 导管消融的患者进行比较。
所有患者均成功消融。与股动脉组相比,桡动脉组的总手术时间(42.8±6.9 分钟)和透视时间(9.7±1.9 分钟)显著缩短(分别为 52.8±8.4 分钟和 11.5±2.1 分钟)(均 P<0.05)。两组的电流应用次数(4.1±0.8 次比 4.4±1.1 次,P>0.05)、功率能量(47.3±7.3 W 比 49.7±6.9 W,P>0.05)和电流应用总时间(110.3±15.6 秒比 112.3±16.5 秒,P>0.05)相似。桡动脉组的住院时间短于股动脉组(4.1±0.9 天比 5.8±1.1 天,P<0.05)。随访期间,所有患者均无心动过速复发。股动脉组 1 例患者发生入路部位并发症,而桡动脉组无患者发生。
经桡动脉入路行 ILVT 导管消融是可行且安全的。